Evidence map›Paper›PMID 27619504›Full record

ArticleBMC cardiovascular disorders2016

Transplantation of EPCs overexpressing PDGFR-β promotes vascular repair in the early phase after vascular injury.

Hang Wang, Yang-Guang Yin, Hao Huang, Xiao-Hui Zhao, Jie Yu, Qiang Wang, Wei Li, Ke-Yin Cai, Shi-Fang Ding

Open access · goldAbstract read
In one paragraph

Article in BMC cardiovascular disorders, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Hang WangCadre Ward Two, Wuhan General Hospital of Guangzhou Military Command, Wuhan, 430070, China.
Yang-Guang YinIntensive Care Unit, The sixth people's hospital of Chongqing, Nan'an District, Chongqing, 400060, China.
Hao HuangClinic center, Shenzhen Hornetcorn Biotechnology Company, Ltd, Shenzhen, 518400, China.
Xiao-Hui ZhaoInstitute of Cardiovascular Science, Xinqiao Hospital, Third Military Medical University, Chongqing, 400037, China.
Jie YuInstitute of Cardiovascular Science, Xinqiao Hospital, Third Military Medical University, Chongqing, 400037, China.
Qiang WangInstitute of Cardiovascular Science, Xinqiao Hospital, Third Military Medical University, Chongqing, 400037, China.
Wei LiInstitute of Cardiovascular Science, Xinqiao Hospital, Third Military Medical University, Chongqing, 400037, China.
Ke-Yin CaiCadre Ward Two, Wuhan General Hospital of Guangzhou Military Command, Wuhan, 430070, China.
Shi-Fang DingInstitute of Cardiovascular Science, Wuhan General Hospital of Guangzhou Military Command, Wuhan, 430070, China. dsfmd2015@163.com.
Army Medical University · CNWuhan General Hospital of Guangzhou · CNBeike Biotechnology (China) · CNGeneral Hospital of Guangzhou Military Command · CNThe Sixth People's Hospital of Shenyang · CNXinqiao Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEndothelial progenitor cells (EPCs) play important roles in the regeneration of the vascular endothelial cells (ECs). Platelet-derived growth factor receptor (PDGFR)-β is known to contribute to proliferation, migration, and angiogenesis of EPCs, this study aims to investigate effects of transplantation of EPCs overexpressing PDGFR-β on vascular regeneration.

methodsWe transplanted genetically modified EPCs overexpressing PDGFR-β into a mouse model with carotid artery injury. After 3 days of EPCs transplantation, the enhanced green fluorescent protein (EGFP)-expressing cells were found at the injury site and the lining of the lumen by laser scanning confocal microscope (LSCM). At 4, 7, and 14 days of the carotid artery injury, reendothelialization was evaluated by Evans Blue staining. Neointima formation was evaluated at day 14 with hematoxylin and eosin (HE) staining by calculating the neointimal area, medial area, and neointimal/media (NI/M) ratio. Intimal cell apoptosis was evaluated using TUNEL assay. Then we tested whether PDGF-BB-induced VSMC migration and PDGF-BB's function in reducing VSMC apoptosis can be attenuated by EPCs overexpressing PDGFR-β in a transwell co-culture system.

resultsOur results showed that EPCs overexpressing PDGFR-β accelerates reendothelialization and mitigates neointimal formation at 14 days after injury. Moreover, we found that there is great possibility that EPCs overexpressing PDGFR-β enhanc VSMC apoptosis and suppress VSMC migration by competitive consumption of PDGF-BB in the early phase after carotid artery injury in mice.

conclusionsWe report the first in vivo and in vitro evidence that transplantation of genetically modified EPC can have a combined effect of both amplifying the reendothelialization capacity of EPCs and inhibiting neointima formation so as to facilitate better inhibition of adverse remodeling after vascular injury.

Indexed as

Gene Expression RegulationAnimalsCarotid Artery InjuriesCell ProliferationCells, CulturedDisease Models, AnimalEndothelial Progenitor CellsEndothelium, VascularMaleMiceMice, Inbred C57BLNeointimaReceptor, Platelet-Derived Growth Factor betaRegenerationReverse Transcriptase Polymerase Chain ReactionRNAReceptor, Platelet-Derived Growth Factor betaRNAEPCsGene therapyNeointimaPDGFR-βReendothelialization

Identifiers

PMID27619504
PMCPMC5020463
OpenAlexW2520346338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.